- Home
- SHO vs QURE Comparison
SHO vs QURE Comparison
Compare SHO & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHO | QURE |
|---|---|---|
| Founded | 1995 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 1995 | 2007 |
Fundamental Metrics
Financial Performance| Metric | SHO | QURE |
|---|---|---|
| Price | $9.29 | $20.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 12 |
| Target Price | $9.31 | ★ $58.55 |
| AVG Volume (30 Days) | 1.9M | ★ 2.4M |
| Earning Date | 11-07-2025 | 11-10-2025 |
| Dividend Yield | ★ 3.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $937,930,000.00 | $15,751,000.00 |
| Revenue This Year | $5.75 | N/A |
| Revenue Next Year | $5.65 | $158.05 |
| P/E Ratio | $962.16 | ★ N/A |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $7.45 | $7.76 |
| 52 Week High | $12.41 | $71.50 |
Technical Indicators
Market Signals| Indicator | SHO | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 54.02 | 28.70 |
| Support Level | $8.84 | $20.55 |
| Resistance Level | $9.48 | $28.50 |
| Average True Range (ATR) | 0.19 | 1.35 |
| MACD | 0.02 | 0.23 |
| Stochastic Oscillator | 69.84 | 12.27 |
Price Performance
Historical ComparisonAbout SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.